<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">56996</article-id><article-id pub-id-type="doi">10.7554/eLife.56996</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>A missense in HSF2BP causing Primary Ovarian Insufficiency affects meiotic recombination by its novel interactor C19ORF57/BRME1</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-179355"><name><surname>Felipe-Medina</surname><given-names>Natalia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94711"><name><surname>Caburet</surname><given-names>Sandrine</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7404-8213</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179356"><name><surname>Sánchez-Sáez</surname><given-names>Fernando</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179918"><name><surname>Condezo</surname><given-names>Yazmine B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179358"><name><surname>de Rooij</surname><given-names>Dirk G</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179359"><name><surname>Gómez-H</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179360"><name><surname>Garcia-Valiente</surname><given-names>Rodrigo</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0444-5587</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179361"><name><surname>Todeschini</surname><given-names>Anne Laure</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179362"><name><surname>Duque</surname><given-names>Paloma</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179364"><name><surname>Sánchez-Martin</surname><given-names>Manuel Adolfo</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179363"><name><surname>Shalev</surname><given-names>Stavit A</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-6214"><name><surname>Llano</surname><given-names>Elena</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-17061"><name><surname>Veitia</surname><given-names>Reiner A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4100-2681</contrib-id><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6217"><name><surname>Pendás</surname><given-names>Alberto M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9264-3721</contrib-id><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">l9</institution>, <institution>Centro de Investigación del Cáncer</institution>, <addr-line><named-content content-type="city">Salamanca</named-content></addr-line>, <country>Spain</country></aff><aff id="aff2"><institution content-type="dept">Molecular Oncology and Ovarian Pathologies, Institut Jacques Monod</institution>, <institution>Université Paris Diderot</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff3"><institution content-type="dept">l9</institution>, <institution>Instituto de Biologia Molecular y Celular del Cancer</institution>, <addr-line><named-content content-type="city">Salamanca</named-content></addr-line>, <country>Spain</country></aff><aff id="aff4"><institution content-type="dept">reproduction</institution>, <institution>Academic Medical Center Amsterdam/Utrecht University</institution>, <addr-line><named-content content-type="city">Utrecht</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff5"><institution content-type="dept">l9</institution>, <institution>Instituto de Biologia Molecular y Celular del Cancer-CSIC-Universidad de Salamanca</institution>, <addr-line><named-content content-type="city">salamanca</named-content></addr-line>, <country>Spain</country></aff><aff id="aff6"><institution content-type="dept">L9</institution>, <institution>Instituto de Biologia Molecular y Celular del Cancer-CSIC-Universidad de Salamanca</institution>, <addr-line><named-content content-type="city">Salamanca</named-content></addr-line>, <country>Spain</country></aff><aff id="aff7"><institution>Institut Jacques Monod, Universite de Paris, CNRS</institution>, <addr-line><named-content content-type="city">paris</named-content></addr-line>, <country>France</country></aff><aff id="aff8"><institution content-type="dept">l9</institution>, <institution>Instituto de Biologia Molecular y Celular del Cancer (CSIC-Universidad de Salamanca)</institution>, <addr-line><named-content content-type="city">Salamanca</named-content></addr-line>, <country>Spain</country></aff><aff id="aff9"><institution>University of Salamanca</institution>, <addr-line><named-content content-type="city">Salamanca</named-content></addr-line>, <country>Spain</country></aff><aff id="aff10"><institution content-type="dept">OBGYN</institution>, <institution>Genetic Institute, Emek Medical Center</institution>, <addr-line><named-content content-type="city">Afula</named-content></addr-line>, <country>Israel</country></aff><aff id="aff11"><institution content-type="dept">Instituto de Biología Molecular y Celular del Cáncer (CSIC-USAL)</institution>, <institution>Campus Miguel de Unamúno</institution>, <addr-line><named-content content-type="city">Salamanca</named-content></addr-line>, <country>Spain</country></aff><aff id="aff12"><institution content-type="dept">Institut Jacques Monod</institution>, <institution>Université Paris Diderot</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff13"><institution content-type="dept">Instituto de Biología Molecular y Celular del Cáncer de Salamanca</institution>, <institution>Campus Miguel de Unamúno</institution>, <addr-line><named-content content-type="city">Salamanca</named-content></addr-line>, <country>Spain</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1529"><name><surname>de Massy</surname><given-names>Bernard</given-names></name><role>Reviewing editor</role><aff><institution>CNRS UM</institution>, <country>France</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>reiner.veitia@ijm.fr</email> (RV);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>amp@usal.es</email> (AP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>08</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e56996</elocation-id><history><date date-type="received"><day>17</day><month>03</month><year>2020</year></date><date date-type="accepted"><day>26</day><month>08</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Felipe-Medina et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Felipe-Medina et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-56996-v1.pdf"/><abstract><p>Primary Ovarian Insufficiency (POI) is a major cause of infertility, but its etiology remains poorly understood. Using whole-exome sequencing in a family with 3 cases of POI, we identified the candidate missense variant S167L in <italic>HSF2BP</italic>, an essential meiotic gene. Functional analysis of the HSF2BP-S167L variant in mouse showed that it behaves as a hypomorphic allele compared to a new loss of function (knock-out) mouse model. <italic>Hsf2bp</italic><sup>S167L/S167L</sup> females show reduced fertility with smaller litter sizes. To obtain mechanistic insights, we identified C19ORF57/BRME1 as a strong interactor and stabilizer of HSF2BP and showed that the BRME1/HSF2BP protein complex co-immunoprecipitates with BRCA2, RAD51, RPA and PALB2. Meiocytes bearing the HSF2BP-S167L variant showed a strongly decreased staining of both HSF2BP and BRME1 at the recombination nodules and a reduced number of the foci formed by the recombinases RAD51/DMC1, thus leading to a lower frequency of crossovers. Our results provide insights into the molecular mechanism of HSF2BP-S167L in human ovarian insufficiency and sub(in)fertility.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003329</institution-id><institution>Ministerio de Economía y Competitividad</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Pendás</surname><given-names>Alberto M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All the experiments were approved by the Ethics Committee for Animal Experimentation of the University of Salamanca (USAL) and the Ethics committee of the Spanish Research Council (CSIC) under protocol #00-245. Accordingly, all the mouse protocols used in this work have been approved by the above mentioned Animal Experimentation committees. Specifically, mice were always housed in a temperature-controlled facility (specific pathogen free, spf) using individually ventilated cages, standard diet and a 12 h light/dark cycle, according to EU law (63/2010/UE) and the Spanish royal law (53/2013) at the &quot;Servicio de Experimentación Animal, SEA. In addition, animal suffering was always minimized and we made every effort to improve animal welfare during the life of the animals.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-56996-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>